EPIDERMAL GROWTH-FACTOR AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN PATIENTS WITH GASTRIC-CANCER

In 19 patients with advanced gastric cancer the expression of epidermal growth factor receptor and epidermal growth factor (EGF) were studied using immuno histochemical techniques. There were 12 males and the mean age of the group was 54.8 years. Most cases belonged in Borrmann's types III or IV. Tumoral cells were positive for EGF receptor in 9 patients (47%), with a strong reaction in 6. Thirteen of 18 subjects were positive for EGF. The reaction for EGF receptor was positive in 20% of 12 patients with intestinal type tumors and in 67% of 7 patients with difuse tumors. Reaction for EGF was positive in 80% of intestinal type tumors and 64% of difuse tumors. Simultaneous positive reactions for both antigens was observed in 5 of 18 patients, all with difuse type tumors. Signet ring cell tumors showed less positivity than less dffferentiated ones. Thus, the expression of EGF and EGF receptor was higher in our patients with advanced gastric cancer than reported elsewhere.